APRA
Register/Login
  • Home
  • About APRA
    • Who We Are
    • What We Do
    • FAQ
    • Our Programs
    • Governance
    • Statement of Independence
    • Founders Statement
    • APRA News
    • Media
    • Press Releases
    • Privacy Policy 07-19-2021
    • Terms and Conditions
  • Patient Alerts
    • All Patients
    • Hospital News
    • Hospital Patients
    • Insurance
    • Laws and Regulations
    • Medical Cost Alerts
    • Medical Devices
    • Medical Treatments
    • Medications
    • Nursing Homes and Skilled Nursing Facilities
    • Seniors
    • Tests and Imaging
  • Patient Tools
    • Medical Bills Toolkit
    • Patient Safety Toolkit
    • FDA Drug and Device Recalls
    • Health Insurance Toolkit
    • Hospital and Surgeon Ratings and Rankings
    • Legal and Medical Forms
    • Medical Costs Toolkit
    • Patient Privacy Toolkit
    • Patient Resources
    • Senior Safety Toolkit
  • Learning Center
    • Health insurance
      • Private Insurance
      • ACA/Obamacare
      • Medicare
    • Medical System
    • Patient Privacy
    • Patient Rights
    • Patient Safety
    • Medical Bills
    • Medical Costs
  • Stories
    • Member Stories
    • Other Medical Stories
    • Share Your Story
  • Testimonials
  • Contact Us
    • Contact Us
    • Leave Feedback
  • Donate

Low levels of chemical that’s been linked to cancer discovered in Zantac, Ranitidine

The FDA says this is the same cancer-linked chemical found previously in blood pressure medications.
By Erika Edwards, NBC News, Sept. 13, 2019.

The Food and Drug Administration announced Friday that low levels of a cancer-linked chemical have been found in samples of the heartburn medication Zantac.

The chemical is an impurity called NDMA, which has been linked to an increased risk for colorectal and uterine cancers.

The FDA said that low levels of NDMA were found in samples of ranitidine, a drug used to treat and prevent heartburn by reducing stomach acid. It’s sold under the brand name Zantac.

It’s unclear where the contamination originated. NDMA is the same chemical that lead to multiple recalls of blood pressure medicines this past year.

The FDA said it’s still evaluating whether the levels found in antacids would pose a health risk to the millions of people who take them, and has said people should not stop taking their heartburn medicine until more is known.

Health officials in Europe announced Friday they, too, are investigating NDMA contamination in ranitidine.

Other heartburn drugs on the market, such as Prevacid, Nexium and Prilosec, have different ingredients and are not included in this alert.

“Patients should be able to trust that their medicines are as safe as they can be and that the benefits of taking them outweigh any risk to their health,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.

“Although NDMA may cause harm in large amounts, the levels the FDA is finding in ranitidine from preliminary tests barely exceed amounts you might expect to find in common foods,” the statement continued.

According to the Centers for Disease Control and Prevention, NDMA has been detected in tobacco smoke, chewing tobacco and cured meats such as bacon.

Ranitidine is sold over the counter as a heartburn medicine, but is also used as a prescription to treat stomach ulcers and gastroesophageal reflux disease.

More than 15 million prescriptions were written for ranitidine in 2016.

Related posts:

Hospitals and Insurers Didn’t Want You to See These Prices. Here’s Why.
For Black kidney patients, an algorithm may help perpetuate harmful racial disparities
Essential Drug Supplies for Virus Patients Are Running Low
[pmpro_levels]
  • Previous post
  • Next post

TAKE ACTION

  • Join
  • Donate
  • Volunteer

Categories

ACA/Obamacare All Patients APRA News COVID Drug and Medical Device Recall Toolkit Health Insurance Toolkit Hospital and Surgeon Ratings and Rankings Hospital News Hospital Patients Insurance Laws and Regulations Legal and Medical Forms Medicaid Medical Bills Medical Bills Toolkit Medical Cost Alerts Medical Costs Medical Costs Toolkit Medical Devices Medical System Medical Treatments Medicare Medications Member Stories Nursing Homes Other Medical Stories Patient Advocates Patient Privacy Patient Privacy Toolkit Patient Resources Patient Rights Patient Safety Patient Safety Toolkit Press Releases Private Insurance Senior Alerts Senior Safety Tests and Imaging

Log In


Join Now | Lost Password?

FOLLOW US

ABOUT APRA

  • Who We Are
  • What We Do

TAKE ACTION

  • Join
  • Donate
  • Volunteer

STAY UP-TO-DATE

SUBSCRIBE TO OUR NEWSLETTER
© 2023. American Patient Rights Association, Inc. By using this site you agree to the Terms of Service, Privacy Policy, and Legal Statement.